Home > Insider Trading > Filing (0001567619-20-004735)

Filing Details

Accession Number:: 0001567619-20-004735
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-02-24 17:52:47
Reporting Period:: 2020-02-20

Accepted Time:: 2020-02-24 17:52:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874716	Idexx Laboratories Inc	IDXX	In Vitro & In Vivo Diagnostic Substances (2835)	010393723

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1184149	W Jonathan Ayers	One Idexx Drive Westbrook ME 04092		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-02-20	23,000	$62.00	832,861	No	4	M	Direct
Common Stock	Disposition	2020-02-20	4,573	$280.34	828,288	No	4	S	Direct
Common Stock	Disposition	2020-02-20	400	$281.30	827,888	No	4	S	Direct
Common Stock	Disposition	2020-02-20	1,000	$282.69	826,888	No	4	S	Direct
Common Stock	Disposition	2020-02-20	1,400	$284.04	825,488	No	4	S	Direct
Common Stock	Disposition	2020-02-20	8,375	$285.98	817,113	No	4	S	Direct
Common Stock	Disposition	2020-02-20	4,600	$286.81	812,513	No	4	S	Direct
Common Stock	Disposition	2020-02-20	1,424	$287.72	811,089	No	4	S	Direct
Common Stock	Disposition	2020-02-20	300	$288.67	810,789	No	4	S	Direct
Common Stock	Disposition	2020-02-20	928	$290.24	809,861	No	4	S	Direct
Common Stock	Disposition	2020-02-21	650	$0.00	809,211	No	5	G	Direct
Common Stock	Disposition	2020-02-21	400	$280.40	137,600	No	4	S	Indirect	by Ayers Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	5	G	Direct
No	4	S	Indirect	by Ayers Family Trust

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right-to-buy)	Disposition	2020-02-20	23,000	$0.00	23,000	$62.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
66,070		2024-02-13	No	4	M	Direct

Footnotes

Represents the weighted average price of the shares sold ranging from a low of $280.04 to a high of $281.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $281.16 to a high of $281.72 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $282.30 to a high of $283.08 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $283.54 to a high of 284.48 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $285.51 to a high of $286.42 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $286.52 to a high of $287.51 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $287.54 to a high of $288.53 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $288.60 to a high of $288.71 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $290.07 to a high of $290.39 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Grant of option to buy 44,535 shares of IDEXX Laboratories, Inc. common stock that became exercisable in five equal annual installments beginning on February 14, 2015 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
Not applicable.